Candel Therapeutics, Inc. (CADL)
NGM · Common · CUSIP 137404109
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CADL and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
137404109
Market Cap
Small Cap
IPO
7/27/2021 · $8.00/share
Business: The cancer treatment paradigm has shifted dramatically over the last decade, providing evidence that the immune system can be reactivated against a patient’s tumor.

Company Contact

CEO
Paul Peter Tak
CFO
Charles Schoch
Headquarters
117 Kendrick St Suite 450, Needham, MA 02494
Phone
617-916-5445
Investor Relations
Sylvia Wheeler · swheeler@wheelhouselsa.com
General Email
info@candeltx.com
Email Form
Material Request Form »
SEC EDGAR Filings
View filings »